May 14, 2020 / 05:45PM GMT
Robert Andrew Koort - Goldman Sachs Group Inc., Research Division - MD
Good afternoon, everybody. This is Bob Koort. I am the GS chemical analyst that runs the equity research in the chemicals space. I've also got from my team, Anthony Walker on, who works with me on Axalta.
And from Axalta, we've got Robert Bryant, who is the President and CEO; Sean Lannon, who is the Executive VP and CFO; and Chris Mecray, who is VP of Treasury, IR and strategy.
Now the format, like the rest of our presentations today, Anthony and I will lead a Q&A session. We've got plenty of questions for Axalta. But as clients on the web portal here, you can also submit your own questions via that portal, and we will prioritize those and ask those questions on your behalf. Those are anonymous questions, so Anthony and I will direct those to the Axalta guys.
Questions and Answers:
Robert Andrew Koort - Goldman Sachs Group Inc., Research Division - MDSo with that, Robert, if we could start off, I thought maybe you could just give us sort of as we're going
Trustpilot
